Working… Menu
Trial record 1 of 11 for:    Boston selinexor
Previous Study | Return to List | Next Study

Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma (BOSTON)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03110562
Recruitment Status : Active, not recruiting
First Posted : April 12, 2017
Last Update Posted : March 22, 2021
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc